Traws Pharma Income Statement (2012-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	2.73M
Operating items
Research & Development (Quarter)	1.85M	1.76M	1.75M	2.00M	2.04M	3.59M	3.77M	4.08M	2.46M	2.46M	2.43M	1.91M	3.96M	5.11M	1.86M	2.51M	2.29M	2.31M	5.04M	4.91M
Selling, General & Administrative (Quarter)	2.85M	2.28M	2.07M	2.19M	2.14M	2.10M	2.02M	2.11M	2.21M	2.69M	2.08M	3.36M	1.98M	3.48M	3.48M	2.75M	1.69M	1.74M	2.33M	2.03M
Restructuring Costs (Quarter)												2.58M	0.85M	0.97M	0.97M	1.85M	0.55M	0.50M	0.89M	0.58M
Other Operating Expenses (Quarter)												-2.58M	116.61M	-0.97M	-0.97M	-1.85M	-0.55M	-0.50M	-0.89M	-0.58M
Operating Expenses (Quarter)	4.70M	4.05M	3.82M	4.19M	4.18M	5.70M	5.79M	6.19M	4.67M	5.15M	4.52M	5.27M	123.41M	8.59M	5.33M	5.26M	3.98M	4.05M	7.37M	6.95M
Operating Income (Quarter)	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M	-6.95M
EBIT (Quarter)	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M	-6.95M
Non-operating items
Other Non Operating Income (Quarter)	-0.01M	0.01M	-0.00M	0.01M	0.10M	0.24M	0.31M	0.36M	0.36M	0.35M	0.28M	0.23M	0.20M	0.06M	-0.21M	0.18M	0.19M	0.10M	0.01M	-0.00M
Net income details
EBT (Quarter)	-4.64M	-3.99M	-177.62M	-4.14M	-4.12M	-5.64M	-175.87M	-6.14M	-4.61M	-5.09M	-4.48M	-5.43M	-123.35M	-10.14M	-7.98M	-5.43M	-1.27M	-4.23M	-7.45M	-7.21M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.23M	-3.45M	-3.76M	-4.12M	-4.02M	-5.40M	-5.42M	-5.78M	-4.25M	-4.74M	-4.18M	-4.98M	-123.14M	-8.47M	-133.27M	21.49M	-0.92M	-3.04M	-7.44M	-7.12M
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	-4.64M	-3.99M	-177.62M	-4.14M	-4.12M	-5.64M	-175.87M	-6.14M	-4.61M	-5.09M	-4.48M	-5.43M	-123.35M	-10.14M	-7.98M	-5.43M	-1.27M	-4.23M	-7.45M	-7.21M
Consolidated Net Income (Quarter)	-4.64M	-3.99M	-177.62M	-4.14M	-4.12M	-5.64M	-175.87M	-6.14M	-4.61M	-5.09M	-4.48M	-5.43M	-123.35M	-10.14M	-7.98M	-5.43M	-1.27M	-4.23M	-7.45M	-7.21M
Income towards Parent Company (Quarter)	-4.64M	-3.99M	-177.62M	-4.14M	-4.12M	-5.64M	-175.87M	-6.14M	-4.61M	-5.09M	-4.48M	-5.43M	-123.35M	-10.14M	-7.98M	-5.43M	-1.27M	-4.23M	-7.45M	-7.21M
Preferred Dividend Payments (Quarter)													-102.37M	-7.04M	-8.50M	6.41M	-0.29M	-0.93M	-2.04M	-1.42M
Net Income towards Common Stockholders (Quarter)	-4.64M	-3.99M	-177.62M	-4.14M	-4.12M	-5.64M	-175.87M	-6.14M	-4.61M	-5.09M	-4.48M	-4.98M	-20.77M	-1.43M	-21.42M	15.08M	-0.62M	-3.04M	-5.40M	-5.69M
Additional items
EPS (Basic) (Quarter)	-7.36	-6.24	-263.81	-4.95	-4.93	-6.74	-210.29	-7.32	-5.49	-6.06	-5.34	-5.92	-20.52	-1.49	-13.79	2.17	-0.11	-0.34	-0.66	-0.53
EPS (Diluted) (Quarter)	-7.36	-6.24	-263.81	-4.95	-4.93	-6.74	-210.29	-7.32	-5.49	-6.06	-5.34	-5.92	-20.52	-1.49	-13.79	2.09	-0.11	-0.34	-0.64	-0.53
Shares Outstanding (Quarter)	0.63M	0.64M	0.67M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	1.01M	0.96M	1.55M	6.97M	5.82M	8.82M	8.23M	10.64M
Shares Outstanding (Diluted) (Quarter)	0.63M	0.64M	0.67M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	1.01M	0.96M	1.55M	7.22M	5.82M	8.82M	8.38M	10.64M
Shares Outstanding (Entity) (Quarter)	0.63M	0.64M	0.67M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	0.84M	1.01M	0.96M	1.55M	6.97M	5.82M	7.13M	9.07M	10.16M
EBITDA (Quarter)	-4.64M	-3.99M	-3.76M	-4.13M	-4.12M	-5.64M	-5.73M	-6.14M	-4.61M	-5.09M	-4.46M	-5.21M	-123.35M	-8.54M	-5.28M	-5.20M	-1.25M	-4.05M	-7.37M	-6.95M
Interest Expenses (Quarter)			173.85M	0.01M			170.13M			949.80	0.02M	0.21M		1.60M	2.70M	0.23M	0.03M	0.17M	0.09M	0.27M
Tax Rate (Quarter)

Research Tools

Datasets

Plans

Developers

Traws Pharma TRAW Income Statement (2012-2026)

Research Tools

Datasets

Plans

Developers

Traws Pharma TRAW Income Statement (2012-2026)

Create an account

Sign In

Reset Password